GANCICLOVIR PHARMACOKINETICS DURING RENAL IMPAIRMENT

被引：28

作者：

LAKE, KD

FLETCHER, CV

LOVE, KR

BROWN, DC

JOYCE, LD

PRITZKER, MR

机构：

[1] ABBOTT NORTHWESTERN HOSP,MINNEAPOLIS HEART INST,TOTAL ARTIFICIAL HEART PROGRAM,MINNEAPOLIS,MN 55407

[2] UNIV MINNESOTA HOSP & CLIN,DEPT PHARMACEUT SERV,MINNEAPOLIS,MN 55455

[3] UNIV MINNESOTA,COLL PHARM,MINNEAPOLIS,MN 55455

[4] UNIV MINNESOTA,DEPT MED,MINNEAPOLIS,MN 55455

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1988年 / 32卷 / 12期

关键词：

D O I：

10.1128/AAC.32.12.1899

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：1899 / 1900

页数：2

共 7 条

[1] PROGRAM PACKAGE FOR SIMULATION AND PARAMETER-ESTIMATION IN PHARMACOKINETIC SYSTEMS [J].

DARGENIO, DZ ;

SCHUMITZKY, A .

COMPUTER PROGRAMS IN BIOMEDICINE, 1979, 9 (02) :115-134

[2] GANCICLOVIR TREATMENT OF CYTOMEGALOVIRUS DISEASE IN TRANSPLANT RECIPIENTS AND OTHER IMMUNOCOMPROMISED HOSTS [J].

ERICE, A ;

JORDAN, C ;

CHACE, BA ;

FLETCHER, C ;

CHINNOCK, BJ ;

BALFOUR, HH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (22) :3082-3087

[3] HUMAN PHARMACOKINETICS OF THE ANTIVIRAL DRUG DHPG [J].

FLETCHER, C ;

SAWCHUK, R ;

CHINNOCK, B ;

DEMIRANDA, P ;

BALFOUR, HH .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (03) :281-286

[4] ACTIVITY OF 9-[2-HYDROXY-1-(HYDROXYMETHYL)ETHOXYMETHYL]GUANINE IN THE TREATMENT OF CYTOMEGALO-VIRUS PNEUMONIA [J].

SHEPP, DH ;

DANDLIKER, PS ;

DEMIRANDA, P ;

BURNETTE, TC ;

CEDERBERG, DM ;

KIRK, LE ;

MEYERS, JD .

ANNALS OF INTERNAL MEDICINE, 1985, 103 (03) :368-373

[5] A COMPETITIVE ENZYME-LINKED-IMMUNOSORBENT-ASSAY TO QUANTITATE ACYCLOVIR AND BW B759U IN HUMAN-PLASMA AND URINE [J].

TADEPALLI, SM ;

QUINN, RP ;

AVERETT, DR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (01) :93-98

[6]

WATSON FS, 1988, J HEART TRANSPLANT, V7, P102

[7]

1986, N ENGL J MED, V314, P801

← 1 →